Shares of Alexion Pharmaceuticals were soaring on Thursday and Friday after the company along with Amgen announced an agreement in a patent battle over blockbuster rare-disease drug Soliris. In a Wednesday filing, a judge with the Patent Trial and Appeal Board said that Alexion and Amgen which brought the suit, had asked to postpone the … Continue reading “Amgen and Alexion Pharmaceuticals Reach Agreement in Patent Battle”
